Medihoney® Barrier Cream helps maintain the skin’s bar-rier
properties and maintain skin moisture and pH.
• Suitableforwetareas*• HelpsmaintainpHoftheskin
• Contains30%Medihoney®AntibacterialHoney
*Medihoney® Barrier Cream can be applied to intact and
at-riskskintoprovideprotectionfrombodyfluidsand
moisture.Itcanbeappliedaroundwoundsandunderskinfolds,wounddressingsandincontinencepadswherea
protectivebarrierwillhelppreventskinbreakdown.
INDICATIONS FOR USE•
Protectsat-riskskinfrombreakdownassociatedwith incontinence and can
be used under incontinence pads
• Canbeusedaroundwoundedgestoprotecttheskin
fromirritationorbreakdowncausedbywoundexudate
• Helpsprotecttheskinfromdamagecausedby frictionorshear
• Helpspreventmaceration
• Helpspreventexcoriation
• HelpsmaintaintheskinpH
• Helpspreventdamagetoskincausedbyfrequent handwashing.
SPECIALLY
FORMULATEDMedihoney®BarrierCreamisspeciallyformulatedwith
arangeofnaturalingredientsand:
• NOAddedcolourorfragrance
• NOLanolin
• NOParabens
• NOSteroids
• NOMineralOils
DIRECTIONS FOR
USEApplytoclean,dryskinthreetimesadayorasrequired.Reapplyafterbathingorateachdressingchange.Suitableforuseonchildren.
Barrier Cream
Derma Sciences Europe Ltd.Suite2 1A Park StreetMaidenhead SL6
1SL U.K.Tel: +44 (0) 1628 625 916 Fax: +44 (0) 1628 671 112
ITEM# PRODUCT NAME PIP CODE NHS CODE
582 Medihoney® 338-7644 ELY289 Barrier Cream 50g
800 Medihoney® 369-1276 ELY374 Barrier Cream Sachet 2g
Medihoney® is a trademark of Medihoney Pty Ltd. and licensed by
Comvita New Zealand Ltd.
Derma Sciences Europe Ltd.Suite2 1A Park StreetMaidenhead SL6
1SL U.K.Tel: +44 (0) 1628 625 916 Fax: +44 (0) 1628 671 112
THE
SKINNormalskinhasanaturallyacidicprotectivemantle.Theacidmantlehelpstohydratetheskinbyprotectingitfromdryingandfromharmfulbacteria2.Skinailmentssuchaseczema
and dermatitis are linked to a disrupted acid
mantlewithsubsequentcolonisationbybacteriasuchas.TheuseofMedihoney®BarrierCreamhelpsmaintaintheskin’s
protective pH. In vitro
studieshaveshowntobeoneofthemostsensitivebac-teriatoMedihoney®AntibacterialHoney™.Medihoney®
BarrierCreamcontains30%
Medihoney®AntibacterialHoney™whichisproventobeef-fectiveagainstarangeofmicroorganisms.
MEDIHONEY® ANTIBACTERIAL
HONEYMedihoney®woundcareandskincareproductscontainmedicalgradeAntibacterialHoney.Advancedbiomedicalresearchhasidentifiedspecificplantsthatproducehoneywithexceptionalantibacterialactivity.Theantibacterialactivityofhoneydiffersaccordingtotheplantspeciesandmayvaryenormouslywithinanyonespecies.Medihoney®
AntibacterialHoney™isastandardisedantibacterialhoney,predominantlysp.selectedforitsbroadrangeofantibac-terial
actions.
In2007,thejournalWoundsfeaturedanarticlethatevaluated
theinvitroactivityofMedihoney®AntibacterialHoney™
againstachallengesetof127clinicalisolateswithmultipleantibioticresistance.ThestudyshowedthattheMedihoney®
AntibacterialHoney™waseffectiveatinhibitingthesebacteria
irrespectiveoftheirlevelofantibioticresistance.
• Particularlyeffectiveagainstand MRSAdowntoa4%dilution1.
References:
1.GeorgeNM&CuttingKF2007.AntibacterialHoney(Medihoney®):in-vitroActivityAgainstClinicalIsolatesofMRSA,VRE,andOtherMultiresistantGram-negativeOrganismsIncluding
Pseudomonas aeroginosa. J Wounds;19(9):231-236
2.TaskapanMO&KumarP2000.Roleofstaphylococcalsuperantigensinatopicdermatitis:fromcolonisationtoinflammation.Annals
of Allergy, Asthma, & Immunology;84(1):3-10
NORMAL SKIN
Basal cells of stratum germinativum
Polyhedral cells of stratum spinosum
Acid mantle
Bacteria colonisation Desmosomes
- stratumgranulosum
Trans-epidermalwater loss
MIC OF 127 DRUG-RESISTANT CLINICAL ISOLATES (1990-2004)Narelle
George, Qld Health Pathology and Scientifi c Services, Royal
Brisbane HospitalBacteria Minimum Inhibitory Concentration
(MIC).
Concentration of Medihoney® (%)Antibacterial Honey™
MRSA / nm* MRSA
ESBL
VRE
Acinetobacter
Pseudomonas aeruginosa
0% 2% 4% 6% 8% 10% 12% 14% 16%
Barrier Cream
Medihoney® is a trademark of Medihoney Pty Ltd. and licensed by
Comvita New Zealand Ltd.
